In 1996, Ichimura et al. revealed that MET protein and its specific ligand, hepatocyte growth factor (HGF), were highly expressed in lung cancer cell lines, as well as in non-small cell lung cancer (NSCLC) biopsies [6,7]. This evidence concerns the gene MET and lung cancer.